Apimeds Pharmaceuticals US, Inc (APUS) stock profile

Frequently asked questions

What does Apimeds Pharmaceuticals US, Inc (APUS) do?

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.

Where is APUS stock listed?

Apimeds Pharmaceuticals US, Inc trades under the ticker APUS on AMEX.

How can I research APUS's financials and filings?

Vantafin provides Apimeds Pharmaceuticals US, Inc's income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the APUS profile.